Fabian Trillsch
Department of Obstetrics and Gynecology
University Hospital, Ludwig-Maximilian-University (LMU) Munich
Fabian Trillsch has not added Biography.
If you are Fabian Trillsch and would like to personalize this page please email our Author Liaison for assistance.
The genetic landscape of 87 ovarian germ cell tumors.
Gynecologic oncology Oct, 2018 | Pubmed ID: 30170975
Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients.
International journal of molecular sciences Dec, 2018 | Pubmed ID: 30597961
Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer.
International journal of molecular sciences Jan, 2019 | Pubmed ID: 30642093
Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients.
International journal of molecular sciences Jun, 2019 | Pubmed ID: 31212758
M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis.
Cells May, 2020 | Pubmed ID: 32429133
Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.
Histochemistry and cell biology Oct, 2020 | Pubmed ID: 32572587
Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer.
Journal of cancer research and clinical oncology Oct, 2020 | Pubmed ID: 32681294
β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation.
Frontiers in endocrinology , 2020 | Pubmed ID: 33042017
Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer.
Translational oncology Jan, 2021 | Pubmed ID: 33069100
Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group.
Journal of gynecologic oncology May, 2021 | Pubmed ID: 33825355
Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs).
Breast cancer research : BCR Apr, 2021 | Pubmed ID: 33849622
Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway.
Biomedicines Jun, 2021 | Pubmed ID: 34206491
Diagnostic workup for endometrioid borderline ovarian tumors (eBOT) requires histopathological evaluation of the uterus.
Journal of ovarian research Jul, 2021 | Pubmed ID: 34233728
Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance Development.
Cancers Jul, 2021 | Pubmed ID: 34359703
The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine.
Cells Sep, 2021 | Pubmed ID: 34571986
Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study.
Gynecologic oncology Apr, 2022 | Pubmed ID: 35115180
PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer.
International journal of molecular sciences Jan, 2023 | Pubmed ID: 36614323
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.
Journal of cancer research and clinical oncology Sep, 2023 | Pubmed ID: 37131060
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro.
Breast cancer (Tokyo, Japan) Sep, 2023 | Pubmed ID: 37199905
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved